Monocacy Therapeutics Inc.

Biotechnology company · Monrovia, Maryland, United States

Monocacy Therapeutics Inc. is a biotechnology company headquartered in Monrovia, Maryland, United States. Its earliest recorded incorporation is in 2025. It has reported private securities offerings to the US SEC, most recently $114,450 sold in a notice filed in 2026.

Profile compiled from public records. Is this your company? Request a correction or update

Monocacy Therapeutics at a glance

Typebiotechnology company

HeadquartersMonrovia, Maryland, United States

Earliest incorporation on record2025

SEC CIK2137361

What does Monocacy Therapeutics do?

Private fundraising reported to the SEC

1 Form D notice; the most recent reported $114,450 sold (2026).

Frequently asked questions about Monocacy Therapeutics

Where is Monocacy Therapeutics headquartered?

Monocacy Therapeutics Inc. is headquartered in Monrovia, Maryland, United States.

What does Monocacy Therapeutics do?

Monocacy Therapeutics Inc. is a biotechnology company.

When was Monocacy Therapeutics founded?

The earliest incorporation on record for Monocacy Therapeutics Inc. is in 2025, according to public company registers.

Similar companies

Exozymes Inc.Monrovia, California, United States
Chromologic LLCMonrovia, California, United States
Pace Diagnostics, Inc.Monrovia, California, United States
Immunova Therapeutics LLCMonrovia, California, United States
Immunowork LLCMonrovia, California, United States
CytoImmune Therapeutics, Inc.Monrovia, California, United States
Recursion PharmaceuticalsSalt Lake City, Utah, United States
Vericel CorpBurlington, Massachusetts, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences